Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Avid Bioservices, Inc.

Avid Bioservices is a drug substance CDMO that offers full lifecycle capabilities, providing services from concept to commercial supply in mammalian cell culture for clinical and commercial biologics.

COM:AVIDBIO

Avid Bioservices

Last Close

12.25

12/11 20:39

Market Cap

469.86M

Beta: -

Volume Today

5.10M

Avg: -

Financials Not Available